Lentiviral vector-based therapy in head and neck cancer (Review).
Lentiviral vector-based therapy in head and neck cancer (Review).
复制标题
DOI:
10.3892/ol.2013.1652
复制
发表时间:
2014-01
期刊:
影响因子:
2.9
通讯作者:
Kung SK
中科院分区:
文献类型:
--
作者:
Upreti D;Pathak A;Kung SK
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common neoplasm worldwide. Despite advances in multimodality treatments involving surgery, radiation and chemotherapy, the five-year survival rate has remained at ~50% for the past 35 years. Therefore, the early detection of recurrent or persistent disease is extremely important. Replication-incompetent HIV-1-based lentiviral vectors have emerged as powerful and safe tools for gene delivery. Commonly, HNSCC is a locoregional disease that presents at or close to the body surface. Thus, HNSCC is amendable to intratumoral injections of gene therapy vectors aimed at correcting defects associated with tumor suppressor genes to induce the direct cytotoxicity of cancer cells or immune modulation to promote antitumor immunity. Current investigations analyzing HNSCC gene mutations and stem cell markers and the cancer immunoediting concept are creating exciting therapeutic opportunities for lentiviral and other gene transfer vectors. The present review reports specific examples of the current applications of lentiviral vectors in HNSCC.
登录
查看更多内容
DOI:
10.1159/000322490
发表时间:
2011-01-01
期刊:
MEDICAL GENETICS IN THE CLINICAL PRACTICE OF ORL
影响因子:
--
作者:
Abuzeid, Waleed M.;Li, Daqing;O'Malley, Bert W., Jr.
通讯作者:
O'Malley, Bert W., Jr.
影响因子:
5.5
作者:
Campoli, M;Chang, CC;Ferrone, S
通讯作者:
Ferrone, S
DOI:
10.1073/pnas.96.6.2988
发表时间:
1999-03-16
影响因子:
11.1
作者:
Case, SS;Price, MA;Crooks, GM
通讯作者:
Crooks, GM
影响因子:
45.3
作者:
Cesana, GC;DeRaffele, G;Kaufman, HL
通讯作者:
Kaufman, HL
影响因子:
4.4
作者:
Almand, B;Clark, JI;Gabrilovich, DI
通讯作者:
Gabrilovich, DI